80 FR 11677 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 42 (March 4, 2015)

Page Range		11677-11677
FR Document		2015-04468

Federal Register, Volume 80 Issue 42 (Wednesday, March 4, 2015)

[Federal Register Volume 80, Number 42 (Wednesday, March 4, 2015)]
[Notices]
[Page 11677]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-04468]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Epidemiologic Study of 
Interstitial Cystitis, DP15-010, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 10:00 a.m.-6:30 p.m., March 26, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Epidemiologic Study of Interstitial Cystitis, DP15-
010, initial review.''
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-04468 Filed 3-3-15; 8:45 am]
BILLING CODE 4163-18-P

Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices 11677

DEPARTMENT OF HEALTH AND forth in Section 552b(c)(4) and (6), Title 5 Audio Conference Call via FTS
HUMAN SERVICES U.S.C., and the Determination of the Director, Conferencing. The USA toll-free, dial-in
Management Analysis and Services Office, number is 1–866–659–0537 with a pass
Centers for Disease Control and CDC, pursuant to Public Law 92–463.
code of 9933701.
Matters for Discussion: The meeting will
Prevention include the initial review, discussion, and
Live Meeting Connection: https://
evaluation of applications received in www.livemeeting.com/cc/cdc/join?id=
Disease, Disability, and Injury response to ‘‘Epidemiologic Study of 48H6RN&role=attend&pw=ABRWH&
Prevention and Control Special Interstitial Cystitis, DP15–010, initial i=i.ics; Meeting ID: 48H6RN; Entry
Emphasis Panel (SEP): Initial Review review.’’ Code: ABRWH.
Contact Person for More Information: M. Status: Open to the public, limited
The meeting announced below Chris Langub, Ph.D., Scientific Review only by the space available. The meeting
concerns Comparison and Validation of Officer, CDC, 4770 Buford Highway NE., space accommodates approximately 100
Screening Tools for Substance Use Mailstop F–80, Atlanta, Georgia 30341, people.
Among Pregnant Women, DP15–003, Telephone: (770) 488–3585, EEO6@cdc.gov.
Background: The Advisory Board was
initial review. The Director, Management Analysis and
Services Office, has been delegated the established under the Energy Employees
SUMMARY: This document corrects a authority to sign Federal Register notices Occupational Illness Compensation
notice that was published in the Federal pertaining to announcements of meetings and Program Act of 2000 to advise the
Register on February 18, 2015, Volume other committee management activities, for President on a variety of policy and
80, Number 32, pages 8661. The time both the Centers for Disease Control and technical functions required to
and date should read as follows: Prevention and the Agency for Toxic implement and effectively manage the
Time and Date: 11:00 a.m.–6:00 p.m., Substances and Disease Registry. new compensation program. Key
March 18, 2015 (Closed). Elaine L. Baker, functions of the Advisory Board include
FOR FURTHER INFORMATION CONTACT: M. Director, Management Analysis and Services providing advice on the development of
Chris Langub, Ph.D., Scientific Review Office, Centers for Disease Control and probability of causation guidelines
Officer, CDC, 4770 Buford Highway NE., Prevention. which have been promulgated by the
Mailstop F46, Atlanta, Georgia 30341, [FR Doc. 2015–04468 Filed 3–3–15; 8:45 am] Department of Health and Human
Telephone: (770) 488–3585, EEO6@ BILLING CODE 4163–18–P
Services (HHS) as a final rule, advice on
cdc.gov. methods of dose reconstruction which
The Director, Management Analysis have also been promulgated by HHS as
and Services Office, has been delegated DEPARTMENT OF HEALTH AND a final rule, advice on the scientific
the authority to sign Federal Register HUMAN SERVICES validity and quality of dose estimation
notices pertaining to announcements of and reconstruction efforts being
meetings and other committee Centers for Disease Control and performed for purposes of the
management activities, for both the Prevention compensation program, and advice on
Centers for Disease Control and petitions to add classes of workers to the
Prevention and the Agency for Toxic Advisory Board on Radiation and Special Exposure Cohort (SEC).
Substances and Disease Registry. Worker Health (ABRWH or Advisory In December 2000, the President
Board), National Institute for delegated responsibility for funding,
Elaine L. Baker, Occupational Safety and Health staffing, and operating the Advisory
Director, Management Analysis and Services (NIOSH) Board to HHS, which subsequently
Office, Centers for Disease Control and delegated this authority to the CDC.
Prevention. In accordance with section 10(a)(2) of
NIOSH implements this responsibility
the Federal Advisory Committee Act
[FR Doc. 2015–04467 Filed 3–3–15; 8:45 am] for CDC. The charter was issued on
(Pub. L. 92–463), and pursuant to the
BILLING CODE 4163–18–P August 3, 2001, renewed at appropriate
requirements of 42 CFR 83.15(a), the
intervals, and will expire on August 3,
Centers for Disease Control and
2015.
DEPARTMENT OF HEALTH AND Prevention (CDC), announces the
Purpose: This Advisory Board is
HUMAN SERVICES following meeting of the
charged with (a) providing advice to the
aforementioned committee:
Secretary, HHS, on the development of
Centers for Disease Control and Times and Dates: guidelines under Executive Order
Prevention 13179; (b) providing advice to the
9:00 a.m.–4:30 p.m., Pacific Daylight
Time, March 25, 2015 Secretary, HHS, on the scientific
Disease, Disability, and Injury
9:00 a.m.–4:30 p.m., Pacific Daylight validity and quality of dose
Prevention and Control Special
Time, March 26, 2015 reconstruction efforts performed for this
Emphasis Panel (SEP): Initial Review
program; and (c) upon request by the
The meeting announced below Public Comment Time and Date: Secretary, HHS, advising the Secretary
concerns Epidemiologic Study of 4:30 p.m.–5:30 p.m.,* Pacific Daylight on whether there is a class of employees
Interstitial Cystitis, DP15–010, initial Time, March 25, 2015 at any Department of Energy facility
review. * Please note that the public comment who were exposed to radiation but for
In accordance with Section 10(a)(2) of period may end before the time whom it is not feasible to estimate their
the Federal Advisory Committee Act indicated, following the last call for radiation dose, and on whether there is
mstockstill on DSK4VPTVN1PROD with NOTICES

(Pub. L. 92–463), the Centers for Disease comments. Members of the public who reasonable likelihood that such
Control and Prevention (CDC) wish to provide public comments radiation doses may have endangered
announces the aforementioned meeting: should plan to attend the public the health of members of this class.
Time and Date: 10:00 a.m.–6:30 p.m., comment session at the start time listed. Matters for Discussion: The agenda for
March 26, 2015 (Closed). Place: Red Lion Richland Hanford the Advisory Board meeting includes:
Place: Teleconference. House, 802 George Washington Way, NIOSH Program Update; Department of
Status: The meeting will be closed to the Richland, Washington 99352, Phone: Labor Program Update; Department of
public in accordance with provisions set 509–946–7611; Fax: 509–943–8564. Energy Program Update; SEC Issues

VerDate Sep<11>2014 18:11 Mar 03, 2015 Jkt 235001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\04MRN1.SGM 04MRN1

Document Created: 2018-02-21 09:31:59
Document Modified: 2018-02-21 09:31:59

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		10:00 a.m.-6:30 p.m., March 26, 2015 (Closed).
FR Citation		80 FR 11677

80 FR 11677 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 42 (March 4, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention